mTORC1 protein kinase functions as a regulator for many cellular metabolic processes, including translation, ribosome biogenesis and autophagy, by either activating or inactivating target proteins by phosphorylation in response to nutrient availability (reviewed in Sarkar 2013, Saxton and Sabatini 2017) . Constitutive activation of mTORC1 may contribute to tumorigenesis, involving a dominant mutation of Rheb. It is positively regulated by Rheb proteins (Inoki, Li, Xu, & Guan, 2003; Takahashi, Nakagawa, Young, & Yamanaka, 2005) and negatively regulated by AMPK (reviewed in Shaw 2009 ). Deregulation of mTORC1 can cause diabetes (Blandino-Rosano et al., 2017) . It is also regulated in lysosomes by the RagA-D, Ragulator v-ATPase, GATOR and folliculin (FLCN) complexes (reviewed in Bar-Peled and Sabatini 2014) .
The hedgehog signaling pathway, first found in Drosophila (Poole, Kauvar, Drees, & Kornberg, 1985) , plays roles in morphogenesis. Hedgehog signaling starts with the binding of hedgehog protein to patched receptor protein, which then releases smoothened proteins. This is followed by release of a Ci-containing protein complex from microtubules, resulting in transcriptional activation of hedgehog target proteins in nuclei by Ci proteins (reviewed in Ingham and McMahon 2001) . The pathway is activated in numerous tumors but not in normal tissues, which is why hedgehog proteins have been used as anticancer drug targets (reviewed in Brechbiel, Miller-Moslin, and Adjei 2014) . Hedgehog signaling is regulated at primary cilia, a complex signaling center involving several signaling pathways (Berbari, O'Connor, Haycraft, & Yoder, 2009; Rohatgi, Milenkovic, & Scott, 2007) .
WDR35 plays a role in the hedgehog signal pathway. Mutations of WDR35 may result in embryonic death in the midgestation phase of mammals with abnormalities characteristic of defects in the hedgehog signaling pathway (Mill et al., 2011) . WDR35 has been implicated in multiple genetic diseases, including Sensenbrenner syndrome (Bacino, Dhar, Brunetti-Pierri, Lee, & Bonnen, 2012; Gilissen et al., 2010; Hoffer, Fryssira, Konstantinidou, Ropers, & Tzschach, 2013) , short rib polydactyly syndromes (Mill et al., 2011) and Ellis-van Creveld syndrome (Caparros-Martin, Luca, & Cartault, 2015) , which indicates that it plays important roles in development, although how it influences development has not been elucidated. In addition, the intraflagellar transport (IFT)-A complex containing WDR35 is involved in selective transport in primary cilia (Fu, Wang, Kim, Li, & Dynlacht, 2016) . WDR35 expression is regulated through mechanisms, including AMPK, ROS and p38 MAPK phosphorylation (Tsunekawa et al., 2013) .
The roles of RagA family proteins have been extensively studied in lysosomes as regulators of mTORC1, but not in other cellular components. We previously reported that RagA interacts with Nop132, a nuclear protein involved in ribosome biogenesis (Sekiguchi, Hayano, Yanagida, Takahashi, & Nishimoto, 2006; Sekiguchi et al., 2004) . In the present study, we found that RagA interacts with WDR35, a cytoplasmic protein localized in the ER and primary cilia, showing novel aspects in RagA-mTORC1 signaling. WDR35 may be another factor involved in mTORC1 signaling through its interaction with RagA family proteins.
| RESULTS

| Identification of the RagA-interacting protein WDR35
To search for roles of RagA-D GTPases in cellular metabolism, we identified a novel RagA-interacting protein using the yeast two-hybrid assay, which allowed us to identify transient protein-protein interactions. The β-galactosidase activities were measured, which indicated strong interactions between RagA and its interacting protein ( Figure 1a ). Nucleotide sequence analyses showed that the RagA-interacting protein was WDR35/IFT121, a hedgehog signaling and primary cilium protein. A pull-down assay was carried out using transiently transfected 293T cells with 3XFLAG-tagged WDR35 and MYC-tagged RagA. MYC-RagA was pulled down using 3XFLAG-WDR35 beads ( Figure 1b , lane 2), confirming the in vivo interaction between RagA and WDR35. Consistently, immunofluorescence analyses showed that WDR35 and RagA were similarly localized in the cytoplasm of 293T cells (Figure 1c) . Mill et al. (2011) reported that WDR35 has significant structural similarity to yeast β′-COP, a protein that plays an essential role in trafficking between the endoplasmic reticulum (ER) and Golgi protein (Mill et al., 2011) . When the amino acid sequences were compared, WDR35 had WD40 repeats and TRP-like repeats as yeast β′-COP, but had an additional sequence in the carboxyl-terminal region. Deletion analyses of WDR35 showed that RagA interacted with the carboxyl-terminal region of WDR35, which was absent in yeast β'-COP and was predicted to harbor a random coil conformation (Figure 1d , e). This suggests that WDR35 and RagA together may be involved in cellular trafficking. A database search revealed homologous forms of WDR35 in Chlamydomonas, Drosophila and Caenorhabditis elegans (Supporting information Figure S1A ), which suggests that WDR35 is well conserved through evolution. Notably, Chlamydomonas WDR35/IFT121 was more conserved in humans than Drosophila (Supporting information Figure S1B ).
| WDR35 is not common in lysosomeenriched fractions
To investigate the biological significance of the interaction between WDR35 and RagA, detailed analyses of the subcellular localizations of each were carried out. We assumed Genes to Cells SEKIGUCHI Et al. that WDR35 might localize in lysosomes with RagA, because it was associated with RagA in vivo as shown in Figure 1b . Lysosome purification using a Lysosome Enrichment Kit (Thermo Fisher Scientific, Waltham, MA, USA) was conducted using 293T cells stably expressing 3XFLAG-tagged WDR35 and MYC-tagged RagA ( Figure  2a ). Lysosomes were found in the top band in the OptiPrep density gradient (Supporting information Figure S2 ) in lane 1 as shown by the presence of the lysosome marker protein, Lamp2. WDR35 was not mainly present in the lysosome fraction ( Figure 2a , lane 2), whereas RagA was found in that fraction and in the fraction containing WDR35, indicating that some RagA is associated with WDR35. In the lysosome fraction, ERp72 protein was also found, indicating that the fraction contained rough ER in addition to lysosome. The β-galactosidase filter assay was carried out as described previously (Sekiguchi, Kamada, Furuno, Funakoshi, & Kobayashi, 2014) , and the activities of the enzyme were expressed as +, weak; ++, middle; and +++, strong. (e) Schematic representation of WDR35. The RagA interaction region is indicated by a black bar. WD40 repeat-1 β-propeller, WD40 repeat-2 and TRP-like repeats are indicated according to a previous study (Mill et al., 2011) . A random coil region was analyzed by DNASIS software (Hitachi Software Engineering, Japan). The slashed bar represents the region of structural similarity between WDR35 and yeast β′-COP Next, we examined whether WDR35 was present in lysosomes associated with RagA using immunofluorescence. First, 293T cells stably expressing 3XFLAG-WDR35 were constructed, and then, confocal laser scanning microscopy was carried out. Consistent with the above results, WDR35 did not co-localize with p18 protein, a lysosomal membrane protein and a binding partner with RagA (Yonehara et al., 2017; Figure 2b) , which suggests that WDR35 was not mainly present in lysosomes. WDR35 did not localize in the Golgi (data not shown). Ding et al. (2017) reported that IFT88, a primary cilium protein, localizes in the ER and plays roles in the movement of IFT88-containing COPII vesicles from the ER exit sites to primary cilia (Ding et al., 2017) . Thus, we determined whether WDR35 was also localized in the ER. We constructed 293T cells stably expressing EGFP-WDR35 and DsRed-ER, an ER marker vector containing the ER targeting sequence of calreticulin and the ER retention sequence (KDEL) at the 5′ and 3′ ends of DsRed2, respectively. We confirmed the localization of WDR35 in the ER via confocal laser scanning microscopy, which indicated co-localization with ER marker protein in paraformaldehyde-fixed cells (Figure 2c ). Taken together, these results indicate that WDR35 localizes mainly in the ER.
| WDR35 is associated with
RagB and RagC
RagB has high homology with RagA, suggesting that it might also be associated with WDR35. Among several RagB splice variants, RagBs (346 aa) was used in this study because it contains additional terminal amino acid residues (33 aa) and a carboxyl-terminal sequence (313 aa) with 98% sequence similarity to RagA (313 aa). To examine the association between RagB and WDR35, T7-tagged RagB was constructed and transfected into 293T cells along with FLAG-tagged WDR35. As shown in Figure 3a (lane 2), RagBs was associated with WDR35.
RagC forms a complex with RagA and plays roles in mTORC1 signaling. Thus, it is likely that it may be associated with WDR35. To examine the association between RagC and WDR35, HA-tagged RagC was constructed and transfected into 293T cells along with FLAG-tagged WDR35. As shown in Figure 3b 
| mTORC1 activity is lower in cells overexpressing WDR35
To elucidate the function of WDR35 in the regulation of mTORC1, we over-expressed WDR35 in 293T cells. A decrease in the phosphorylated form of S6K, a substrate of mTORC1 ( Figure 4a , lane 2), was found, suggesting that WDR35 may negatively regulate mTORC1 activity.
To further determine whether WDR35 regulates mTORC1 activity, it was exogenously over-expressed in 293T cells, and the phosphorylation of ribosome S6 protein, a target protein of S6K, was examined in cells via immunofluorescence microscopy. Phosphorylation sites on ribosome S6 protein involved Ser240 and Ser244, whose phosphorylations were repressed by rapamycin treatment (Pende et al., 2004) . As shown in Figure 4b Genes to Cells
were found in 293T cells over-expressing WDR35. Next, we determined whether the presence of RagA, RagB or RagC affected the inhibitory effects of WDR35 on mTORC1 activity. RagA, RagB or RagC knockout cells were constructed using the CRISPR/Cas9 system (Figure 4c ). In the absence of any of these proteins, phosphorylation of ribosome S6 protein was not decreased in cells over-expressing WDR35 ( Figure  4d -f, arrowheads), which suggests that WDR35 might regulate mTORC1 through RagA, RagB and RagC. Both RagA and RagB proteins might be required for the inhibitory effects of WDR35 on mTORC1.
| The GDP-bound state of RagA is preferentially associated with WDR35
We noticed that the association between RagA and WDR35 was significant but weak. As a Ras-like GTPase, RagA is found in two possible forms (GDP and GTP), acting as a molecular switch; thus, each form might interact with different proteins. Hence, we examined the association between WDR35 and RagA T21L (GDP form) and Q66L (GTP form) using a pull-down assay. WDR35 showed a stronger association with the GDP form (Figure 5a , lane 1) than the GTP form (lane 2), which suggests that WDR35 preferentially interacts with the inactive form of RagA. Thus, the interaction shown in Figure 1b might be that between the inactive forms of RagA and WDR35. Next, the lysosome fraction was purified from 293T cells stably expressing FLAG-WDR35 and MYC-RagA (GDP form) as described in Figure 2a . Most of the GDP forms were not present in the lysosome fraction (Figure 5b , lane 1) but were present in the supernatant fraction where WDR35 was present (lane 2). Immunofluorescence examination indicated that the majority of WDR35 with the GDP form of RagA was co-localized in the cytoplasm (Figure 5c , upper panels), although the GTP form of RagA was also present in the cytoplasm in methanol-fixed 293T cells transiently transfected with both the WDR35 and GTP form of RagA (Figure 5c , lower panels). Higher co-localization of RagA and WDR35 might be due to the methanol fixation treatment, which could have caused leakage of free RagA from the cytosol, allowing the detection of membrane-or high-molecular-weight cellular component-bound RagA. These results suggest that the inactive form of RagA is associated with WDR35 in cytoplasmic membrane fractions, where it may regulate mTORC1 activity. When cells were exposed to nutrient deprivation or stress unfavorable to cells, mTORC1 activity was down-regulated. Thus, we investigated whether the WDR35/RagA interaction might change in response to these stimuli. Amino acid deprivation or H 2 O 2 exposure inhibits mTORC1 activity (Li et al., 2010; Tang, Qin, & Wang, 2018) . A region where WDR35 and RagA co-localized was found (arrowhead in Figure 5d ), when 293T cells were deprived of amino acids (middle panels) or incubated with 1 mM H 2 O 2 for 1 hr (lower panels). The proteasome inhibitor MG132 can also inhibit mTORC1 (Liu, Knutzen, Krauss, Schweiger, & Chiang, 2011) . MG132 and H 2 O 2 treatment slightly increased the interaction between WDR35 and RagA (Supporting information Figure S3 ).
F I G U R E 3
| DISCUSSION
RagA, an mTORC1 activator, interacted with WDR35, a hedgehog signaling protein, which suggests that WDR35 is involved in the mTORC1 signaling pathway. WDR35 strongly bound to the GDP form of RagA, but less to the GTP form, which implies that it affected mTORC1 activity through RagA in a nucleotide-binding-dependent manner. RagA is positively regulated by nucleotide exchange proteins in the regulator complex (Bar-Peled, Schweitzer, Zoncu, & Sabatini, 2012) and negatively regulated by GTPase-activating proteins in the GATOR complex (Bar-Peled et al., 2013) . Thus, our results suggest that WDR35 is an additional regulator of the mTORC1 pathway. Rag GTPase activates mTORC1 by recruiting the mTORC1 protein to lysosomes. WDR35 might regulate mTORC1 activity through a similar mechanism, by recruiting the inactive form of RagA to ER membranes other than those of lysosomes, where mTORC1 elicits its activity. Consistently, the GDP form of RagA was mainly found not in a lysosome-enriched fraction but in the supernatant fraction with WDR35 ( Figure 5b, lane 2) . It is also possible that a part of the newly synthesized RagA in ribosomes might be in an inactive form and associated with WDR35 in the ER and transported to primary cilia. In this manner, WDR35 might be an upstream regulator of mTORC1.
Both RagA activity (Efeyan et al., 2014) and mTORC1 activity (Gangloff et al., 2004; Murakami et al., 2004) are essential for the development of mouse embryos, which suggests that RagA might play roles in early development by regulating mTORC1 activity. Primary cilia are signal centers in various signal transduction pathways during development, including the hedgehog and Wnt signal pathways (Berbari et al., 2009 ). Thus, RagA may play critical roles in these pathways in mouse development. Moreover, there is cross talk between mTOR and hedgehog pathways in the presence of TNF-α in esophageal adenocarcinoma cells (Wang, Ding, & Yen, 2012) . In the present study, we showed that WDR35, a hedgehog signal protein, interacts with RagA, and this interaction could be another form of cross talk between mTOR and hedgehog pathways. Thus, Hedgehog signaling and the mTORC1 pathway could be mediated by RagA and WDR35.
WDR35 is also known as IFT121, a component of IFT-A found in primary cilia (Behal et al., 2012; Blacque et al., 2006) , where it plays roles in formation and is required for retrograde intraflagellar transport (Fu et al., 2016) . Primary cilia formation is required for nutrient sensing and signal transduction induced by autophagy, which is negatively regulated by mTORC1 (Parmigiani et al., 2014; Tang et al., 2013) . It is possible that WDR35/IFT121 in the IFT-A complex binds the inactive form of RagA, resulting in the inhibition of mTORC1 activity. Thus, WDR35 might maintain lower levels of mTORC1 activity in the region of primary cilia formation.
Dynein light chain Tctex-type 1, a protein that regulates the length of primary cilia and cell cycle entry (Li et al., 2011) , interacts with RagA, along with adenovirus E3 14.7 kDa (Lukashok, Tarassishin, Li, & Horwitz, 2000) .
Thus, it might localize RagA to the cilia and regulate primary cilia formation and cell cycle progression. Both IFT-A and dynein play roles in retrograde intraflagellar transport, and RagA GTPase might be another player in primary cilia formation and/or retrograde intraflagellar transport.
| EXPERIMENTAL PROCEDURES
| Cells and media
293T cells were cultured in Dulbecco's modified Eagle's medium containing 5% fetal calf serum and were maintained in a humidified atmosphere containing 5% CO 2 at 37°C.
| Yeast two-hybrid assay
Saccharomyces cerevisiae Y190 strain was used for the yeast two-hybrid assay. Yeast cells were grown in the following media: YPD (2% glucose, 2% peptone and 1% yeast extract), SD-Trp, SD-Leu and SD-His (2% glucose and 0.67% yeast nitrogen base without amino acids, supplemented with all essential amino acids except for tryptophan, leucine and histidine) as described previously (Sekiguchi, Hirose, Nakashima, Ii, & Nishimoto, 2001) . Screening to isolate genes of RagAbinding protein was carried out using pAS404-RagA, and the pACT2-human cDNA library was introduced into Y190 as described previously (Sekiguchi et al., 2004) . The transformed cells were plated on SD-L-T-H and 3AT, and colonies were picked. The quantitative β-galactosidase assay was carried out as previously described (Sekiguchi et al., 2001) . DNAs purified from yeast colonies were transformed into Escherichia coli DH5α, followed by determination of their DNA sequences.
| Immunoprecipitation, Western blotting and antibodies
Immunoprecipitation and Western blotting were conducted as previously described (Sekiguchi et al., 2004) . The cell lysis buffer contained 50 mM Tris-HCl (pH.7.4), 1 mM EDTA, 0.15 M NaCl, 0.4 mM p-amidinophenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 0.1% dodecyl beta maltoside and a protease inhibitor cocktail (1:200 dilution; Nakarai Chemicals, Kyoto, Japan). A Lysosome Enrichment Kit for tissue and cultured cells (cat. no. 89839) was purchased from Thermo Fisher Scientific. The lysosome fraction was purified as recommended by the supplier and as shown in Supporting information Figure  S2 . Briefly, cells were suspended in lysosome enrichment reagent A and homogenized using a Dounce homogenizer on ice. After homogenization, lysosome enrichment reagent B was added. The cell lysate was applied onto
